Medicinal and Pharmaceutical Chemistry — Design, Synthesis and Testing of Novel Anti-Cancer Agents


Are you interested in applying your laboratory expertise to the development of new drugs for cancer and other diseases?  Become part of a multi-disciplinary team involved in drug discovery


Professor Paul Groundwater, Professor David (Dai) Hibbs

Research Location

Sydney Pharmacy School

Program Type



The importance of the over-expression of the EGFR family of receptors in human cancers has been well documented.  This project will build upon a preliminary study performed in our laboratories which involved the design of agents which target EGFR dimerisation (using in silico screening), to generate new hit compounds for biological testing in a range of assays already in place, involving cell proliferation, EGFR dimerisation and signalling, and cytotoxicity.  The successful student will be involved in all aspects of the project, from molecular modeling, synthesis and characterisation of the hit compounds to biological testing in cell based assays using cancer models with oncogenic EGFR activity.

Want to find out more?

Contact us to find out what’s involved in applying for a PhD. Domestic students and International students

Contact Research Expert to find out more about participating in this opportunity.

Browse for other opportunities within the Sydney Pharmacy School .


EGFR, medicinal, pharmaceutical, chemistry, synthesis, Cancer, agents, receptors, cytotoxicity, cell

Opportunity ID

The opportunity ID for this research opportunity is: 937

Other opportunities with Professor Paul Groundwater

Other opportunities with Professor David (Dai) Hibbs